Hospitalisations and surgery in Crohn's disease

Gut

Volumn 61, Issue 4, 2012, Pages 622-629

  Bernstein, Charles N ^a   Loftus Jr , Edward V ^b   Ng, Siew C ^c   Lakatos, Peter L ^d   Moum, Bjorn ^e  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MAYO CLINIC   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB;

ASIA; CROHN DISEASE; EUROPE; GEOGRAPHIC DISTRIBUTION; HOSPITALIZATION; HUMAN; INTESTINE SURGERY; NORTH AMERICA; PRIORITY JOURNAL; PROBABILITY; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SURGERY; SURGERY RATE; SURGICAL RISK;

CROHN DISEASE; DIGESTIVE SYSTEM SURGICAL PROCEDURES; EUROPE; HOSPITALIZATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NORTH AMERICA;

EID: 84857798954     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-301397     Document Type: Review

References (55)

1. Sands BE. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology 2004;126:1518-32. (Pubitemid 38649870)
2. Henriksen M, Jahnsen J, Lygren I, et al Ibsen Study Group. Clinical course in Crohn's disease: results of a five-year population-based follow-up study (the IBSEN study). Scand J Gastroenterol 2007;42:602-10. (Pubitemid 46633816)
3. Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, et al. The natural history of Crohn's disease in population based cohorts. Am J Gastroenterol 2010;105:289-97.
4. Silverstein MD, Loftus EV, Sandborn WJ, et al. Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology 1999;117:49-57. (Pubitemid 29297619)
5. Nguyen GC, Nugent Z, Shaw S, et al. Outcomes of patients with Crohn's disease improved from 1988 to 2008 and were associated with increased specialist care. Gastroenterology 2011;141:90-7.
6. Talley NJ, Abreu MT, Achkar JP, et al American College of Gastroenterology IBD Task Force. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol 2011;106(Suppl 1):S2-25.
7. Munkholm P, Langholz E, Davidsen M, et al. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol 1995;30:699-706.
8. Odes S, Vardi H, Friger M, et al European Collaborative Study on Inflammatory Bowel Disease. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology 2006;131:719-28. (Pubitemid 44307060)
9. Bernstein CN, Nabalamba A. Hospitalization, surgery and readmission rates of IBD in Canada: a population-based study. Am J Gastroenterol 2006;101:110-18. (Pubitemid 43381717)
10. Longobardi T, Bernstein CN. Health care resource utilization in inflammatory bowel disease. Clin Gastroenterol Hepatol 2006;4:731-43. (Pubitemid 43825804)
11. Ingle SB, Loftus EV, Harmsen WS, et al. Hospitalizations and inpatient corticosteroid use among Crohn's disease patients from Olmsted County, Minnesota, 1970-2001. Gastroenterology 2007;132(4 Suppl 2):A-658.
12. Ingle SB, Loftus EV, Harmsen WS, et al. Hospitalization rates for Crohn's disease patients in Olmsted County, Minnestoa in the prebiologic era. Am J Gastroenterol 2007;102(Suppl 2):S487.
13. Peyrin-Biroulet L, Loftus EV, Harmsen WS, et al. Emergency room visits and hospitalizations for Crohn's disease in a population-based cohort. Gastroenterology 2010;138(5 Suppl 1):S-532.
14. Bewtra M, Su C, Lewis JD. Trends in hospitalization rates for inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol 2007;5:597-601.
15. Sonnenberg A. Hospitalization for inflammatory bowel disease in the United States between 1970 and 2004. J Clin Gastroenterol 2009;43:297-300.
16. Sewell JL, Yee HF, Inadomi JM. Hospitalizations are increasing among minority patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2010;16:204-7.
17. Nguyen GC, Tuskey A, Dassopoulos T, et al. Rising hospitalization rates for inflammatory bowel diseases in the United States between 1998 and 2004. Inflamm Bowel Dis 2007;13:1529-35.
18. Ananthakrishnan AN, McGinley EL, Binion DB, et al. A nationwide analysis of changes in severity and outcomes of inflammatory bowel disease hospitalizations. J Gastrointest Surg 2011;15:267-76.
19. Sonnenberg A, Richardson PA, Abraham NS. Hospitalizations for inflammatory bowel disease among U.S. military veterans 1975-2006. Dig Dis Sci 2009;54:1740-5.
20. Herrinton L, Liu L, Fireman B, et al. Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005. Gastroenterology 2009;137:502-11.
21. Truelove SC, Ellis H, Webster TU. Placement of a double-barrelled ileostomy in ulcerative colitis and Crohn's disease of the colon: a preliminary report. Br Med J 1965;1:150-3.
22. Kivel RM, Taylor KB, Oberhelman H. Response to bypass ileostomy in ulcerative colitis and Crohn's disease of the colon. Lancet 1967;2:632-6.
23. D'Haens GR, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998;114:262-7. (Pubitemid 28093532)
24. Truelove SC, Pena AS. Course and prognosis of Crohn's disease. Gut 1976;17:192-201.
25. Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology 1985;88:1818-25. (Pubitemid 15052293)
26. Hellers G. Crohn's disease in Stockholm County from 1955-1974. A study of epidemiology, results of surgical treatment and long term prognosis. Acta Chir Scand Suppl 1979;490:1-84.
27. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and postoperative recurrence in Crohn's disease. Ann Surg 2000;231:38-45. (Pubitemid 30043937)
28. Binder V, Hendriksen C, Kreiner S. Prognosis in Crohn's disease-based on results from a regional patient group from the county of Copenhagen. Gut 1985;26:146-50. (Pubitemid 15105140)
29. Munkholm P, Langholz E, Davidsen M, et al. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993;105:1716-23. (Pubitemid 24002788)
30. Vind I, Riis L, Jess T, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005; A population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006;101:1274-82. (Pubitemid 43833122)
31. Solberg IC, Vatn MH, Hoie O, et al. Clinical course in Crohn's disease results of a Norwegian population-based ten-year follow up study. Clin Gastroenterol Hepatol 2007;5:1430-8. (Pubitemid 350181602)
32. Wolters FL, Russel MG, Sijbrandij J, et al. Phenotype at diagnosis predicts recurrence rates in Crohn's disease. Gut 2006;55:1124-30. (Pubitemid 44085679)
33. Cosnes J, Nion-Larmurier I, Beaugerie L, et al. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005;54:237-41. (Pubitemid 40139240)
34. Ramadas AV, Gunesh S, Thomas GA, et al. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut 2010;59:1200-6.
35. Lakatos L, Kiss LS, Gyula D, et al. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006. Inflamm Bowel Dis 2011;17:2558-65.
36. Lakatos PL, David G, Pandur T, et al. Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: a population-based study from Western Hungary 1977-2008. J Crohns Colitis 2011;5:122-8.
37. Lakatos PL, Golovics PA, David G, et al. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2008. Am J Gastroenterol 2012 Jan 10. doi:10.1038/ajg.2011.448
38. Agrez MV, Valente RM, Pierce W, et al. Surgical history of Crohn's disease in a well-defined population. Mayo Clin Proc 1982;57:747-52. (Pubitemid 13221589)
39. Dhillon SL, Loftus EV Jr, Tremaine WJ, et al. The natural history of surgery for Crohn's disease in a population-based cohort from Olmsted County, Minnesota. Am J Gastroenterol 2005;100:S305.
40. Peyrin-Biroulet L, Loftus EV, Harmsen WS, et al. Cumulative incidence of and risk factors for major abdominal surgery in a population-based cohort of Crohn's disease. Gastroenterology 2010;138(5 Suppl 1):S-199.
41. Ye BD, Yang SK, Cho YK, et al. Clinical features and long-term prognosis of Crohn's disease in Korea. Scand J Gastroenterol 2010;45:1178-85.
42. Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm Bowel Dis 2004;10:646-51. (Pubitemid 39276475)
43. Oriuchi T, Hiwatashi N, Kinouchi Y, et al. Clinical course and long term prognosis of Japanese patients with Crohn's disease: predictive factors, rates of operation, and mortality. J Gastroenterol 2003;38:942-53. (Pubitemid 37455781)
44. Ljung T, Karlen P, Schmidt D, et al. Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County. Gut 2004;53:849-53. (Pubitemid 38662135)
45. Picco MF, Zubiaurre I, Adluni M, et al. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease. Am J Gastroenterol 2009;104:2754-9.
46. Punati J, Markowitz J, Lerer T, et al. Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. Inflamm Bowel Dis 2008;14:949-54.
47. Feagan BG, Panaccione R, Sandborn WJ, et al. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study. Gastroenterology 2008;135:1493-9.
48. Lichtenstein GR, Yan S, Bala M, et al. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology 2005;128:962-9.
49. Nugent Z, Blanchard JF, Bernstein CN. A population-based study of health-care resource use among infliximab users. Am J Gastroenterol 2010;105:2009-16.
50. Bernell O, Lapidus A, Hellers G. Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease. Br J Surg 2000;87:1697-701.
51. Lapidus A, Bernell O, Hellers G, et al. Clinical course of colorectal Crohn's disease: a 35 year follow-up study of 507 patients. Gastroenterology 1998;114:1151-60. (Pubitemid 28243900)
52. Whelan G, Farmer RG, Fazio VW, et al. Recurrence after surgery in Crohn's disease: relationship to location of disease (clinical pattern) and surgical indication. Gastroenterology 1985;88:1826-33. (Pubitemid 15052294)
53. Chow DK, Sung JJ, Wu JC, et al. Upper gastrointestinal tract phenotype of Crohn's disease is associated with early surgery and further hospitalization. Inflamm Bowel Dis 2009;15:551-7.
54. Scammell BE, Andrews H, Allan RN, et al. Results of proctocolectomy for Crohn's disease. Br J Surg 1987;74:671-4. (Pubitemid 17108415)
55. Lewis JD, Schoenfeld P, Lichtenstein GR. An evidence-based approach to studies of the natural history of gastrointestinal disease: recurrence of symptomatic Crohn's disease after surgery. Clin Gastroenterol Hepatol 2003;1:229-336.